PDX 305R was derived from a radical prostatectomy specimen obtained from a patient who died rapidly from their disease; it is a de novo large cell neuroendocrine tumor negative for AR and expressing markers of neuroendocrine differentiation [51] (Supplementary Fig. 3). This evidence concerns the gene AR and neuroendocrine neoplasm.